(NASDAQ: CLPT) Clearpoint Neuro's forecast annual revenue growth rate of 12.8% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 6.03%, and it is also forecast to beat the US market's average forecast revenue growth rate of 12.01%.
Clearpoint Neuro's revenue in 2026 is $45,493,000.On average, 4 Wall Street analysts forecast CLPT's revenue for 2026 to be $1,602,072,315, with the lowest CLPT revenue forecast at $1,507,832,767, and the highest CLPT revenue forecast at $1,682,849,070. On average, 4 Wall Street analysts forecast CLPT's revenue for 2027 to be $1,824,400,717, with the lowest CLPT revenue forecast at $1,746,572,955, and the highest CLPT revenue forecast at $1,884,790,958.
In 2028, CLPT is forecast to generate $2,105,580,756 in revenue, with the lowest revenue forecast at $2,023,008,962 and the highest revenue forecast at $2,167,509,602.